These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2450230

  • 1. Quinidine attenuates sympathetically induced poststenotic myocardial ischemia.
    Schipke J, Schulz R, Tölle T, Heusch G, Thämer V.
    J Cardiovasc Pharmacol; 1987 Dec; 10(6):622-6. PubMed ID: 2450230
    [Abstract] [Full Text] [Related]

  • 2. Adenosine, dipyridamole and isosorbide dinitrate are ineffective to prevent the sympathetic initiation of poststenotic myocardial ischemia.
    Heusch G, Deussen A, Schipke J, Thämer V.
    Arzneimittelforschung; 1986 Jul; 36(7):1045-8. PubMed ID: 3768070
    [Abstract] [Full Text] [Related]

  • 3. Pain and myocardial ischemia: the role of sympathetic activation.
    Thämer V, Deussen A, Schipke JD, Tölle T, Heusch G.
    Basic Res Cardiol; 1990 Jul; 85 Suppl 1():253-66. PubMed ID: 2091607
    [Abstract] [Full Text] [Related]

  • 4. Cardiac sympathetic nerve activity and progressive vasoconstriction distal to coronary stenoses: feed-back aggravation of myocardial ischemia.
    Heusch G, Deussen A, Thämer V.
    J Auton Nerv Syst; 1985 Aug; 13(4):311-26. PubMed ID: 4031366
    [Abstract] [Full Text] [Related]

  • 5. Role of cardiac sympathetic nerves in the genesis of myocardial ischemia distal to coronary stenoses.
    Heusch G, Deussen A, Schipke J, Vogelsang H, Hoffmann V, Thämer V.
    J Cardiovasc Pharmacol; 1985 Aug; 7 Suppl 5():S13-8. PubMed ID: 2410728
    [Abstract] [Full Text] [Related]

  • 6. Sympathetic mechanisms in poststenotic myocardial ischemia.
    Heusch G, Schipke J, Thämer V.
    J Cardiovasc Pharmacol; 1986 Aug; 8 Suppl 3():S33-40. PubMed ID: 2429111
    [Abstract] [Full Text] [Related]

  • 7. Effect of a new alpha 2-adrenoceptor antagonist on poststenotic coronary resistance and myocardial function.
    Kröger K, Schipke JD, Thämer V.
    Arzneimittelforschung; 1990 Aug; 40(8):871-5. PubMed ID: 1978679
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Significance of the sympathetic nervous system for the coronary circulation].
    Heusch G, Thämer V.
    Z Kardiol; 1984 Sep; 73(9):543-51. PubMed ID: 6506839
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of alpha-adrenergic coronary constriction by calcium-antagonists.
    Heusch G, Deussen A, Guth BD.
    Basic Res Cardiol; 1990 Sep; 85 Suppl 1():219-28. PubMed ID: 1965399
    [Abstract] [Full Text] [Related]

  • 17. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ.
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [Abstract] [Full Text] [Related]

  • 18. Postsynaptic adrenoceptor-mediated vasoconstriction in coronary and femoral vascular beds.
    Chen DG, Dai XZ, Bache RJ.
    Am J Physiol; 1988 May; 254(5 Pt 2):H984-92. PubMed ID: 2896466
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.